Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73M Buy
68,646
+64,715
+1,646% +$5.22M 0.25% 129
2026
Q1
$340K Sell
3,931
-17,907
-82% -$1.68M 0.02% 453
2025
Q4
$2.06M Hold
21,838
0.13% 245
2025
Q3
$2.35M Hold
21,838
0.15% 230
2025
Q2
$2.37M Hold
21,838
0.13% 268
2025
Q1
$1.81M Buy
21,838
+13,432
+160% +$1.07M 0.13% 275
2024
Q4
$659K Buy
+8,406
New +$697K 0.06% 419
2021
Q4
Sell
-9,300
Closed -$437K 1009
2021
Q3
$437K Buy
9,300
+365
+4% +$17.3K 0.03% 507
2021
Q2
$399K Buy
8,935
+2,135
+31% +$96.2K 0.03% 555
2021
Q1
$291K Buy
+6,800
New +$262K 0.02% 625
2020
Q2
Sell
-9,400
Closed -$240K 818
2020
Q1
$240K Buy
+9,400
New +$271K 0.02% 522

Other funds holding STN

PDT Partners's STN Position: Q2 2026 in Review

PDT Partners increased its Stantec (STN) stake by 1,646% in Q2 2026, buying an estimated $5.22M and bringing the position to 68,646 shares worth $4.73M. The position accounts for 0.25% of the portfolio, ranked #129.

PDT Partners first reported a position in STN in Q1 2020 and has held it in 11 quarters since. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • PDT Partners held 68,646 shares of Stantec worth $4.73M as of Q2 2026.
  • PDT Partners bought 64,715 Stantec shares in Q2 2026, an estimated $5.22M.
  • Stantec made up 0.25% of PDT Partners's portfolio in Q2 2026, its #129 holding.
  • PDT Partners first reported a position in Stantec in Q1 2020 and has held it in 11 quarters since.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.